Abstract | OBJECTIVE: The purpose of this trial was to investigate the short-term safety and efficacy of risperidone in the treatment of chronic tic disorders in children and adolescents. METHOD: This was an 11-week open-label trial and included seven subjects (five boys and two girls) with a mean age of 12.9 +/- 1.9 years. The sample included five patients with Tourette's syndrome and two with chronic motor tic disorder. The children were seen at baseline and for two follow-up visits. Three children had a comorbid diagnosis of obsessive-compulsive disorder (OCD). RESULTS: Clinical response, as measured by the Yale Global Tic Severity Scale and the Children's version of the Yale-Brown Obsessive Compulsive Scale, revealed a statistically significant reduction in tic scores ranging from 26% [corrected] to 66%. One of three children with comorbid OCD showed substantial improvement; the other two subjects showed no change. The most frequent side effect was weight gain, which ranged from 8 to 14 lb. CONCLUSIONS:
|
Authors | P J Lombroso, L Scahill, R A King, K A Lynch, P B Chappell, B S Peterson, C J McDougle, J F Leckman |
Journal | Journal of the American Academy of Child and Adolescent Psychiatry
(J Am Acad Child Adolesc Psychiatry)
Vol. 34
Issue 9
Pg. 1147-52
(Sep 1995)
ISSN: 0890-8567 [Print] United States |
PMID | 7559308
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Antipsychotic Agents
- Risperidone
|
Topics |
- Adolescent
- Antipsychotic Agents
(therapeutic use)
- Attention Deficit Disorder with Hyperactivity
(complications, drug therapy)
- Child
- Chronic Disease
- Dose-Response Relationship, Drug
- Female
- Humans
- Male
- Obsessive-Compulsive Disorder
(complications, drug therapy)
- Pilot Projects
- Risperidone
(administration & dosage, adverse effects, therapeutic use)
- Severity of Illness Index
- Tic Disorders
(complications, drug therapy)
- Tourette Syndrome
(complications, drug therapy)
- Weight Gain
|